Guardant Health, Inc. (GH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Azenta, Inc.

The Ensign Group, Inc.

Amedisys, Inc.

Encompass Health Corp.

Option Care Health, Inc.

Teladoc Health, Inc.

Acadia Healthcare Co., Inc.

Agilon Health, Inc.

Ginkgo Bioworks Holdings, Inc.

Guardant Health, Inc.

DaVita, Inc.

Why is Guardant Health, Inc. ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -26.18% of over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 94.25%, its profits have fallen by -8.2%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Guardant Health, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Guardant Health, Inc.

94.25%

3.21

57.08%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

27.92%

EBIT Growth (5y)

-26.18%

EBIT to Interest (avg)

-162.24

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.78

Sales to Capital Employed (avg)

0.69

Tax Ratio

0.28%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-115.15

EV to EBIT

-26.94

EV to EBITDA

-29.63

EV to Capital Employed

50.98

EV to Sales

11.98

PEG Ratio

Dividend Yield

ROCE (Latest)

-189.24%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -184.76 MM

NET PROFIT(HY)

Higher at USD -207.12 MM

NET SALES(Q)

Highest at USD 281.27 MM

RAW MATERIAL COST(Y)

Fallen by -5.09% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 4.45 times

DEBTORS TURNOVER RATIO(HY)

Highest at 7.92 times

-13What is not working for the Company

CASH AND EQV(HY)

Lowest at USD 1,781.61 MM

INTEREST(Q)

Highest at USD 1.18 MM

PRE-TAX PROFIT(Q)

Lowest at USD -116.12 MM

NET PROFIT(Q)

Lowest at USD -114.39 MM

EPS(Q)

Lowest at USD -1

Here's what is working for Guardant Health, Inc.

Operating Cash Flow

Highest at USD -184.76 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales

Highest at USD 281.27 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (USD MM)

Net Sales

At USD 281.27 MM has Grown at 39.37%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Inventory Turnover Ratio

Highest at 4.45 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 7.92 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -5.09% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Guardant Health, Inc.

Interest

At USD 1.18 MM has Grown at 25.13%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest

Highest at USD 1.18 MM

in the last five periods and Increased by 25.13% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Pre-Tax Profit

Lowest at USD -116.12 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -114.39 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD -1

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv

Lowest at USD 1,781.61 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents